Experienced Leadership with Proven Successin Development and Commercialization
Matthew Nuñez
CEO
Currently serves as the President & Director of Smart Health Diagnostics Company (SHDC) as well as the CEO of Muse Microscopy, Inc. A seasoned technology entrepreneur and executive with more than 25 years of experience in bringing new products and concepts to commercial markets. He has special expertise in biomarker discovery and development and has been recognized as an innovator in a scientific journal for innovations in biomarker discovery based in systems biology. Matthew co-founded Liquid Biosciences, which focuses on advanced evolutionary computing and forms of AI and bioinformatics tools, and is highly proficient in complex mechanical engineering. Read More
He has established a commercial partnership with the University of Pennsylvania’s School of Translational Medicine and has developed one of the world’s first multi-omic biomarker discovery laboratories. His work has resulted in novel discoveries in oncology, autoimmune disease, drug response companion diagnostics, as well as kidney and liver disease. This has led to a current development partnership with Mayo Clinic. A named inventor in several technologies and has been granted US patents in drug response to the TNF Class of drugs, which is the second largest in the world. Matthew has served on public and private company boards, held numerous C-suite roles, and is a multi-time founder. Overall, he brings a wealth of knowledge and experience to the table.
Larry Dentice
President
Currently serves as the CEO & Director of Smart Health Diagnostics Company (SHDC) and the President of Muse Microscopy, Inc. In these commercialization roles he oversees the distribution of diagnostic and imaging platforms. Over 40 years of experience in the diagnostics imaging field, as a senior healthcare executive with proven expertise and experience in engineering, service, manufacturing, marketing, sales, and business operations. Read More
He has worked for several Fortune 500 companies in the past, including GE Healthcare where he was a member of the engineering teams responsible for developing and servicing of CT, MRI, and Nuclear Medicine products, this allowed him to advance into management positions at GE. He also worked at Philips Medical Systems, where he was responsible for the $4B imaging product portfolio, marketing, commercialization, sales, service, applications, and dealer networks. In addition, he served as the SVP and General Manager for the $3B medical imaging business at Toshiba America Medical Systems/Canon Medical Systems. This role included overseeing operations, engineering, product portfolio development, finance, marketing, HR, sales, and service. He was also the President of the imaging division at Esaote, where he was responsible for operations, finance, marketing, sales, and dealer network of the ultrasound and MR product portfolio.
Furthermore, he has held positions and board seats for the Radiological Society of North America (RSNA), the Medical Imaging & Technology Alliance (MITA), a division of the National Electrical Manufacturers Association (NEMA) and Phillips/ De Lage Landen finance board member.
Lance White
CFO
Started with Smart Health Diagnostics Company (SHDC), a parent company of Muse Microscopy, Inc., as the Chief Financial Officer in June 2023. Began career as an analyst on Wall Street. Obtained a master’s in accounting, became a CPA, and spent several years in public accounting at KPMG, conducting audits on public companies and providing transaction advisory services. Read More
Transitioned to Goldman Sachs, as a controller in the Merchant Banking Division, overseeing finance and accounting operations for several of the firm’s private equity and debt funds.
Over the last few years, went in-house with VC firms and their underlying portfolio companies. Joined the team here to establish an effective accounting and financial reporting framework, formulate and execute business strategy, and implement scalable operational procedures to prepare the company for SmartHealth’s anticipated rapid growth.
Bryan Davies
CTO
Currently holds the position of Chief Technology Officer at Muse Microscopy, Inc. A successful PhD researcher with a proven track record as a technology chief. Has led agile R&D groups to win multi-billion-dollar efforts in AI across various business domains. These include satellite imagery, aviation navigation, digital surgical microscopy, and DNA forensics. He has provided thought leadership for product lines worth over a billion dollars. Read More
Additionally, he has made R&D investments at three of the largest technology groups in the US. He has created successful technology spin-offs and start-ups, guiding the strategic direction of IRAD programs, all of which have shaped the product technology strategy and future-proofed enterprise architectures.